G. Doyle

Oncology · 2004–2014

A researcher in the Science corpus: 8 papers; trusts 2 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

Whom G. Doyle trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. D. de Bono

Who trusts G. Doyle overall

  1. M. Miller
  2. L. Terstappen
  3. K. Pantel

Papers from G. Doyle's perspective

Ordered by how strongly the researchers G. Doyle trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. (Journal of Clinical Oncology)
  2. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. (New England Journal of Medicine)
  3. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited (Nature Reviews. Cancer)
  4. Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. (Journal of Clinical Oncology)
  5. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System (Clinical Cancer Research)
  6. Circulating tumor cells (CTC) detection: clinical impact and future directions. (Cancer Letters)
  7. Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival (Clinical Cancer Research)
  8. Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer (Clinical Cancer Research)
  9. Circulating Tumor Cell Number as a Prognostic Marker in Progressive Castration-Resistant Prostate Cancer: Use in Clinical Practice and Clinical Trials (The Lancet Oncology)
  10. Isolation of rare circulating tumour cells in cancer patients by microchip technology (Nature)

Their papers